| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 03/14/2000 | US6037521 Transgenic mouse expressing an β-Amyloid transgene |
| 03/14/2000 | US6036951 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 03/14/2000 | CA2163229C Method for examining neurovirulence of polio virus |
| 03/09/2000 | WO2000012742A1 Method for remodelling an animal genome by zygotic transfer of a site-specific recombinase |
| 03/09/2000 | WO2000012720A2 Elongase genes and uses thereof |
| 03/09/2000 | WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 03/09/2000 | WO2000012709A2 Phelix: a testis-specific protein expressed in cancer |
| 03/09/2000 | WO2000012702A2 Human genes differentially expressed in colorectal cancer |
| 03/09/2000 | WO2000012679A1 Novel ubiquitin ligases as therapeutic targets |
| 03/09/2000 | WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
| 03/09/2000 | WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor |
| 03/09/2000 | WO2000011943A1 Post-pubertary amygdala lesions as animals models for cns disorders |
| 03/09/2000 | WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 03/09/2000 | WO1999062333A9 Bacteriophage-based transgenic fish for mutation detection |
| 03/09/2000 | CA2633074A1 Elongase genes and uses thereof |
| 03/09/2000 | CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor |
| 03/09/2000 | CA2341064A1 Novel ubiquitin ligases as therapeutic targets |
| 03/09/2000 | CA2340594A1 Method for remodelling an animal genome by zygotic transfer of a site-specific recombinase |
| 03/09/2000 | CA2340592A1 Phelix: a testis-specific protein expressed in cancer |
| 03/08/2000 | EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 03/08/2000 | EP0983391A1 Method for diagnosing alzheimer disease |
| 03/08/2000 | EP0983353A1 Methods and compositions for diagnosis and treatment of cancer |
| 03/08/2000 | EP0983352A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
| 03/08/2000 | EP0983074A2 Non-myeloablative tolerogenic treatment |
| 03/08/2000 | EP0873491A4 Ceramic packing with channels for thermal and catalytic beds |
| 03/08/2000 | EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 03/07/2000 | US6034297 Transplanting viable, hepatitis c virus-infected, human hepatocytes into liver parenchyma of a scid/scid mouse host |
| 03/07/2000 | US6033658 Mass production and long-term preservation of fungivorous nematodes to protect plants against soil-borne plant pathogens |
| 03/07/2000 | US6033657 Mass production and long-term preservation of fungivorous nematodes and uses thereof |
| 03/02/2000 | WO2000011204A2 Homer interacting proteins |
| 03/02/2000 | WO2000011151A2 Direct oviduct transgenesis |
| 03/02/2000 | WO2000011147A1 Inbred mhc-homozygous miniature swine and uses thereof |
| 03/02/2000 | WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 03/02/2000 | WO2000010389A1 BLOCKADE OF GLUCOSE TOXICITY TO THE β CELLS IN THE ISLETS OF LANGERHANS |
| 03/02/2000 | WO2000010383A1 Method for modifying chromosomes |
| 03/02/2000 | WO2000010382A1 Model animal with visualized nerve network |
| 03/02/2000 | WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 03/01/2000 | EP0981633A2 Hybrid molecules for optically detecting changes in cellular microenvironments |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981614A1 Prostate cancer-specific marker |
| 03/01/2000 | EP0981604A1 Targeted gene modification by parvoviral vectors |
| 03/01/2000 | EP0981602A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031149 Exhibit specific phenotypes; for screening compounds which act as antagonists or agonists |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030794 Determining subtype or isoform bound by agent by incubating agent with one or more cell lines homozygous for a disruption in one or more of its receptor genes, determining the amount of agent, and comparing to control cells |
| 02/24/2000 | WO2000009731A1 Transgenic parasites as gene therapy agents |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009686A1 Gene |
| 02/24/2000 | WO2000009674A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000008924A1 Method of performing transgenesis |
| 02/24/2000 | DE19836382A1 Neues Tiermodell zur Entstehung und Therapie von Diabetes Mellitus New animal model for the pathogenesis and therapy of diabetes mellitus |
| 02/24/2000 | CA2340242A1 Method of performing transgenesis |
| 02/24/2000 | CA2340199A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339518A1 Gene |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/23/2000 | CN2364687Y Stereoscopic special device for rearing silkworms |
| 02/23/2000 | CN1245011A Method for producing anti-pylorospirobacillus immune eggs |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028173 Amino acid sequence of polypeptide involved in axon outgrowth |
| 02/22/2000 | US6027935 Gene up-regulated in regenerating liver |
| 02/17/2000 | WO2000008209A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 02/17/2000 | WO2000008137A2 Transgenic animals having a modified glycoprotein v gene |
| 02/17/2000 | WO2000008132A1 Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof |
| 02/17/2000 | WO2000007438A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 02/17/2000 | CA2339876A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 02/17/2000 | CA2337694A1 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 02/17/2000 | CA2337693A1 Transgenic animals having a modified glycoprotein v gene |
| 02/16/2000 | EP0979872A1 Animal model for the development and therapy of diabetes mellitus |
| 02/16/2000 | EP0979298A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979277A1 Novel human tumour suppressor gene |
| 02/16/2000 | EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/16/2000 | CN1244341A Maggot breeding machine |
| 02/15/2000 | US6025540 Transgenic non-human mammal comprising a dna sequence encoding human extracellular superoxide dismutase (human ec-sod) or a variant thereof which is expressed in the milk |
| 02/15/2000 | US6025539 IL-5 transgenic mouse |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025183 Recombinant expression vector of a dna sequence encoding human acetylcholinesterase and a human promoter; for screening assays to test treatments for alzheimer's disease, retinal photoreceptor degeneration, hematopoietic disorders |
| 02/15/2000 | US6025155 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 02/10/2000 | WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |
| 02/10/2000 | WO2000006726A2 Delta-related polypeptides |
| 02/10/2000 | WO2000006716A1 Growth differentiation factor-11 |
| 02/10/2000 | WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | WO2000006708A1 Novel polypeptide |
| 02/10/2000 | WO2000006704A2 Hematopoietic cell composition for use in transplantation |
| 02/10/2000 | WO2000006700A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 02/10/2000 | WO2000006199A1 Kvlqt1 - a long qt syndrome gene |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006193A1 Equine system for non-surgical artificial insemination |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | CA2340855A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | CA2338981A1 .alpha.1,3-fucosyltransferase nucleic acid and polypeptide |
| 02/10/2000 | CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | CA2338194A1 Equine system for non-surgical artificial insemination |